References
- Cappuzzo F, Moro-Sibilot D, Gautschi O, et al. Management of crizotinib therapy for ALK-rearranged non-small cell lung carcinoma: an expert consensus. Lung Cancer. 2015;87:89–95. PMID: 25576294. doi:https://doi.org/10.1016/j.lungcan.2014.12.010.
- Kazandjian D, Blumenthal GM, Chen HY, et al. FDA approval summary: crizotinib for the treatment of metastatic non-small cell lung cancer with anaplastic lymphoma kinase rearrangements. Oncologist. 2014;19:e5–11. PMID: 25170012. doi:https://doi.org/10.1634/theoncologist.2014-0241.
- Camidge DR, Bang YJ, Kwak EL, et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol. 2012;13:1011–1019. PMID: 22954507. doi:https://doi.org/10.1016/S1470-2045(12)70344-3.
- Kwak EL, Bang YJ, Camidge DR, et al. Anaplastic lymphoma kinase inhibition in non–small-cell lung cancer. N Engl J Med. 2010;363:1693–1703. PMID: 20979469. doi:https://doi.org/10.1056/NEJMoa1006448.
- Ishii T, Iwasawa S, Kurimoto R, Maeda A, Takiguchi Y, Kaneda M. Crizotinib-induced abnormal signal processing in the retina. PLoS One. 2015;10:e0135521. PMID: 26271036. doi:https://doi.org/10.1371/journal.pone.0135521.
- Chun SG, Iyengar P, Gerber DE, Hogan RN, Timmerman RD. Optic neuropathy and blindness associated with crizotinib for non–small-cell lung cancer with EML4-ALK translocation. J Clin Oncol. 2015;33:e25–e26. PMID: 24616318. doi:https://doi.org/10.1200/JCO.2013.49.1985.
- Ooto S, Hangai M, Tomidokoro A, et al. Effects of age, sex, and axial length on the three-dimensional profile of normal macular layer structures. Invest Ophthalmol Vis Sci. 2011;52:8769–8779. PMID: 21989721. doi:https://doi.org/10.1167/iovs.11-8388.
- Moorthy RS, Valluri S, Jampol LM. Drug-induced uveitis. Surv Ophthalmol. 1998;42:557–570. PMID: 9635904. doi:https://doi.org/10.1016/S0039-6257(97)00130-6.
- Agarwal M, Majumder PD, Babu K, et al. Drug-induced uveitis: A review. Indian J Ophthalmol. 2020;68:1799–1807. PMID: 32823396. doi:https://doi.org/10.4103/ijo.IJO_816_20.
- Altiparmak UE. Toxic optic neuropathies. Curr Opin Ophthalmol. 2013;24:534–539. PMID: 24100370. doi:https://doi.org/10.1097/ICU.0000000000000001.
- London NJ, Garg SJ, Moorthy RS, Cunningham ET. Drug-induced uveitis. J Ophthal Inflamm Infect. 2013;3:43. PMID: 23522744. doi:https://doi.org/10.1186/1869-5760-3-43.
- Moorthy RS, Valluri S. Ocular toxicity associated with systemic drug therapy. Curr Opin Ophthalmol. 1999;10:438–446. PMID: 10662249. doi:https://doi.org/10.1097/00055735-199912000-00012.
- Nakano N, Hangai M, Nakanishi H, et al. Macular ganglion cell layer imaging in preperimetric glaucoma with speckle noise-reduced spectral domain optical coherence tomography. Ophthalmology. 2011;118:2414–2426. PMID: 21924499. doi:https://doi.org/10.1016/j.ophtha.2011.06.015.
- Nukada M, Hangai M, Mori S, et al. Imaging of localized retinal nerve fiber layer defects in preperimetric glaucoma using spectral-domain optical coherence tomography. J Glaucoma. 2014;23:150–159. PMID: 23059486. doi:https://doi.org/10.1097/IJG.0b013e3182707456.
- Shields JA, Shields CL, Singh AD. Metastatic neoplasms in the optic disc: the 1999 Bjerrum Lecture: part 2. Arch Ophthalmol. 2000;118:217–224. PMID: 10676787. doi:https://doi.org/10.1001/archopht.118.2.217.
- Fukuda R, Tanabe T, Sawamura H, Kawata M, Tsuji H, Kaburaki T. Case of metastatic pulmonary carcinoma in optic disc diagnosed from results of biopsy performed during vitrectomy surgery. Graefes Arch Clin Exp Ophthalmol. 2011;249:1883–1887. PMID: 21845391. doi:https://doi.org/10.1007/s00417-011-1770-1.
- Gordon LK. Paraneoplastic syndromes in neuro-ophthalmology. J Neuroophthalmol. 2015;35:306–314. PMID: 26172160. doi:https://doi.org/10.1097/WNO.0000000000000280.
- Igarashi N, Sawamura H, Kaburaki T, Aihara M. Anti-collapsing response-mediating protein-5 antibody-positive paraneoplastic perioptic neuritis without typical neurological symptoms. Neuroophthalmology. 2016;41:24–29. PMID: 28228834. doi:https://doi.org/10.1080/01658107.2016.1241283.